Clinical Trial Detail

NCT ID NCT03159117
Title Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

melanoma

Therapies

PF-06688992

Age Groups: adult senior

No variant requirements are available.